PIOGLITAZONE HYDROCHLORIDE

PIOGLITAZONE HYDROCHLORIDE was reported 1257 times

PIOGLITAZONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAND-ARM VIBRATION SYNDROME 2 0.1333
1 ANTERIOR CAPSULAR RUPTURE 1 0.1250
2 TOTAL LUNG CAPACITY ABNORMAL 45 0.1157
3 PULMONARY VASCULITIS 47 0.0874
4 CAPILLARITIS 23 0.0833
5 SPIROMETRY ABNORMAL 47 0.0786
6 MITE ALLERGY 35 0.0534
7 MALIGNANT SPINAL CORD COMPRESSION 2 0.0476
8 CUPULOLITHIASIS 1 0.0417
9 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 30 0.0409
10 MYCOTIC ALLERGY 34 0.0398
11 CYTOTOXIC CARDIOMYOPATHY 3 0.0366
12 DUST ALLERGY 35 0.0357
13 THYROIDITIS CHRONIC 2 0.0308
14 CONJUNCTIVITIS ALLERGIC 39 0.0263
15 DENTAL EXAMINATION ABNORMAL 1 0.0244
16 NEURITIS 34 0.0220
17 BLADDER TRANSITIONAL CELL CARCINOMA STAGE I 1 0.0217
18 EYELASH HYPERPIGMENTATION 1 0.0200
19 CARDIOVASCULAR DECONDITIONING 1 0.0172
20 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 34 0.0167
21 RESPIRATORY SYMPTOM 46 0.0162
22 CELLS IN URINE 1 0.0130
23 NORMOCHROMIC NORMOCYTIC ANAEMIA 37 0.0123
24 FORCED EXPIRATORY VOLUME DECREASED 33 0.0116
25 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 1 0.0106
26 THYROIDITIS SUBACUTE 3 0.0103
27 BLOOD ERYTHROPOIETIN INCREASED 1 0.0101
28 ADRENOMEGALY 2 0.0096
29 MEDICATION MONITORING ERROR 2 0.0092
30 NEOPLASM SKIN 14 0.0090
31 GENITAL DISORDER 1 0.0075
32 GALLBLADDER CANCER STAGE IV 1 0.0072
33 ABDOMINAL WALL DISORDER 2 0.0069
34 PULMONARY ALVEOLAR HAEMORRHAGE 36 0.0064
35 HYPERMAGNESAEMIA 4 0.0061
36 NEUROLOGICAL SYMPTOM 34 0.0059
37 PSEUDOPORPHYRIA 2 0.0058
38 PTERYGIUM 2 0.0058
39 EYELID INJURY 1 0.0057
40 BLADDER TRANSITIONAL CELL CARCINOMA 8 0.0056
41 ARTERIOSCLEROSIS CORONARY ARTERY 36 0.0054
42 DIABETIC KETOSIS 2 0.0053
43 ADENOCARCINOMA METASTATIC 1 0.0049
44 DUODENAL POLYP 1 0.0047
45 EMPHYSEMATOUS CYSTITIS 1 0.0047
46 POUCHITIS 4 0.0046
47 CHOLELITHOTOMY 1 0.0046
48 URINARY TRACT DISCOMFORT 2 0.0043
49 CONTINUOUS POSITIVE AIRWAY PRESSURE 1 0.0043
50 GASTRITIS BACTERIAL 2 0.0043
51 ANTERIOR CHAMBER FLARE 1 0.0043
52 VASCULITIS 48 0.0041
53 ALCOHOL PROBLEM 1 0.0041
54 ARTERIOSCLEROSIS 37 0.0039
55 HYPOGLYCAEMIC COMA 11 0.0038
56 GALLBLADDER OBSTRUCTION 1 0.0038
57 COAGULATION FACTOR DECREASED 1 0.0037
58 APPLICATION SITE MASS 1 0.0036
59 BLOOD GROWTH HORMONE INCREASED 2 0.0036
60 VULVOVAGINAL MYCOTIC INFECTION 14 0.0036
61 ANDROGENETIC ALOPECIA 1 0.0035
62 FULL BLOOD COUNT ABNORMAL 36 0.0034
63 CERVICOBRACHIAL SYNDROME 2 0.0033
64 BLOOD BETA-D-GLUCAN INCREASED 1 0.0033
65 DISABILITY ASSESSMENT SCALE SCORE INCREASED 1 0.0033
66 CHRONIC GASTRITIS 7 0.0031
67 OBSTRUCTIVE AIRWAYS DISORDER 34 0.0031
68 BLOOD VISCOSITY DECREASED 1 0.0030
69 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
70 ALCOHOLIC LIVER DISEASE 1 0.0029
71 BRAIN STEM INFARCTION 3 0.0029
72 GIARDIASIS 1 0.0029
73 LACUNAR INFARCTION 7 0.0029
74 NODULE 38 0.0029
75 TONGUE PARALYSIS 2 0.0028
76 DIABETIC ULCER 2 0.0028
77 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 47 0.0028
78 HAEMORRHOIDAL HAEMORRHAGE 13 0.0027
79 HYPOPROTEINAEMIA 5 0.0026
80 ALBUMIN URINE PRESENT 1 0.0026
81 ARACHNOID CYST 1 0.0025
82 DEATH OF RELATIVE 1 0.0025
83 COVID-19 IMMUNISATION 2 0.0024
84 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 3 0.0023
85 HAEMANGIOMA OF SKIN 1 0.0023
86 DIABETIC NEPHROPATHY 5 0.0023
87 DEGENERATIVE BONE DISEASE 1 0.0023
88 ANGIOSARCOMA 1 0.0022
89 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
90 CORONAVIRUS TEST POSITIVE 2 0.0019
91 KETOSIS 2 0.0018
92 PULMONARY FIBROSIS 35 0.0018
93 BLOOD INSULIN INCREASED 1 0.0018
94 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 2 0.0018
95 CARDIAC HYPERTROPHY 2 0.0018
96 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
97 INFECTION REACTIVATION 2 0.0017
98 PO2 DECREASED 2 0.0017
99 EYE ULCER 1 0.0017
100 AORTIC CALCIFICATION 1 0.0017
101 BICUSPID AORTIC VALVE 1 0.0017
102 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 2 0.0017
103 AURICULAR SWELLING 1 0.0017
104 DUODENITIS 5 0.0016
105 POSTOPERATIVE WOUND COMPLICATION 2 0.0016
106 TRANSITIONAL CELL CARCINOMA 2 0.0015
107 CELLULITIS STAPHYLOCOCCAL 1 0.0015
108 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
109 URETERIC OBSTRUCTION 2 0.0015
110 PREMENSTRUAL SYNDROME 2 0.0015
111 DIABETIC METABOLIC DECOMPENSATION 2 0.0014
112 GRANULOMATOUS LIVER DISEASE 1 0.0014
113 APPENDIX DISORDER 2 0.0014
114 DELAYED GRAFT FUNCTION 1 0.0014
115 PNEUMATOSIS INTESTINALIS 4 0.0014
116 ANTERIOR CHAMBER CELL 1 0.0014
117 DYSLALIA 1 0.0014
118 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
119 HAEMOPTYSIS 37 0.0013
120 CHOLANGITIS ACUTE 1 0.0013
121 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
122 DIZZINESS EXERTIONAL 1 0.0013
123 GASTROINTESTINAL SURGERY 1 0.0013
124 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
125 COAGULATION TIME PROLONGED 2 0.0013
126 BLOOD KETONE BODY INCREASED 1 0.0013
127 URINE KETONE BODY PRESENT 2 0.0013
128 GINGIVAL INFECTION 1 0.0012
129 HYPOGLYCAEMIA 60 0.0012
130 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
131 DYSBIOSIS 1 0.0012
132 EUGLYCAEMIC DIABETIC KETOACIDOSIS 5 0.0012
133 DENTAL DISCOMFORT 1 0.0012
134 BLADDER NEOPLASM 2 0.0012
135 HYPOTHYROIDISM 37 0.0012
136 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
137 FOLLICULAR LYMPHOMA 1 0.0011
138 ABDOMINAL SEPSIS 1 0.0011
139 CANDIDA SEPSIS 1 0.0011
140 ANAEMIA OF CHRONIC DISEASE 1 0.0011
141 ANEURYSM RUPTURED 1 0.0011
142 BLOOD CHOLESTEROL DECREASED 2 0.0011
143 BUNDLE BRANCH BLOCK 1 0.0011
144 CARDIOMEGALY 13 0.0011
145 PANCREATIC CARCINOMA METASTATIC 3 0.0011
146 HYPOXIA 37 0.0010
147 FIBULA FRACTURE 3 0.0010
148 NECK INJURY 3 0.0010
149 DACTYLITIS 1 0.0010
150 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
151 HYPOGLYCAEMIC UNCONSCIOUSNESS 2 0.0010
152 DIABETIC NEUROPATHY 5 0.0010
153 HAEMANGIOMA OF LIVER 1 0.0010
154 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
155 BLADDER DYSFUNCTION 1 0.0010
156 BONE MARROW OEDEMA 1 0.0010
157 AXILLARY MASS 1 0.0010
158 BONE DEMINERALISATION 1 0.0009
159 ALLERGY TO ANIMAL 1 0.0009
160 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
161 CARDIAC FAILURE ACUTE 6 0.0009
162 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
163 BACTERIAL TEST POSITIVE 2 0.0009
164 PSEUDOMEMBRANOUS COLITIS 2 0.0009
165 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
166 CARBON DIOXIDE DECREASED 1 0.0009
167 BILIRUBIN CONJUGATED INCREASED 2 0.0009
168 HYPERTRIGLYCERIDAEMIA 5 0.0009
169 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
170 WHEEZING 50 0.0008
171 BILE DUCT CANCER 1 0.0008
172 PRODUCTIVE COUGH 40 0.0008
173 ESCHERICHIA TEST POSITIVE 1 0.0008
174 DYSPLASIA 1 0.0008
175 BLADDER PROLAPSE 1 0.0008
176 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
177 HYPERPARATHYROIDISM SECONDARY 2 0.0008
178 BREECH PRESENTATION 1 0.0008
179 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
180 DIABETIC KETOACIDOSIS 19 0.0008
181 FRACTURED COCCYX 1 0.0008
182 BAND SENSATION 1 0.0008
183 GLUCOSE URINE PRESENT 1 0.0008
184 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
185 BLOOD BILIRUBIN ABNORMAL 1 0.0008
186 ADENOCARCINOMA PANCREAS 1 0.0008
187 POOR VENOUS ACCESS 8 0.0008
188 LACTIC ACIDOSIS 25 0.0008
189 ANAEMIA POSTOPERATIVE 1 0.0008
190 PSYCHOMOTOR SKILLS IMPAIRED 2 0.0008
191 ANORGASMIA 2 0.0007
192 LUNG DISORDER 36 0.0007
193 CORNEAL ABRASION 1 0.0007
194 ABSCESS ORAL 1 0.0007
195 DEAFNESS UNILATERAL 4 0.0007
196 BILIARY TRACT DISORDER 1 0.0007
197 APPLICATION SITE INFLAMMATION 1 0.0007
198 HAEMORRHOIDS 14 0.0007
199 HYPERGLYCAEMIA 26 0.0007
200 BODY TEMPERATURE DECREASED 7 0.0007
201 CARDIAC FAILURE CHRONIC 3 0.0007
202 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 49 0.0007
203 DIABETES MELLITUS NON-INSULIN-DEPENDENT 1 0.0007
204 THROMBOSIS 55 0.0007
205 BILIARY DILATATION 1 0.0007
206 DARK CIRCLES UNDER EYES 1 0.0007
207 CEREBROVASCULAR DISORDER 2 0.0007
208 REBOUND ACID HYPERSECRETION 2 0.0007
209 URINE ABNORMALITY 3 0.0007
210 BLOOD GLUCOSE ABNORMAL 12 0.0006
211 NON-CARDIAC CHEST PAIN 2 0.0006
212 ORTHOPNOEA 2 0.0006
213 PNEUMONIA VIRAL 2 0.0006
214 BLADDER CANCER STAGE II 1 0.0006
215 ANGINA UNSTABLE 4 0.0006
216 POSTURE ABNORMAL 2 0.0006
217 INFLAMMATORY BOWEL DISEASE 6 0.0006
218 POLYP 4 0.0006
219 CEREBELLAR INFARCTION 1 0.0006
220 BILIARY DYSKINESIA 1 0.0006
221 B-CELL LYMPHOMA 2 0.0006
222 ENTERITIS INFECTIOUS 1 0.0006
223 GLIOBLASTOMA 1 0.0006
224 BLOOD AMYLASE INCREASED 1 0.0006
225 LEFT VENTRICULAR FAILURE 2 0.0006
226 APLASTIC ANAEMIA 3 0.0006
227 EXTREMITY NECROSIS 1 0.0006
228 DEFAECATION URGENCY 4 0.0006
229 EMOTIONAL POVERTY 1 0.0006
230 BLOOD LACTIC ACID INCREASED 3 0.0006
231 DEPRESSIVE SYMPTOM 2 0.0006
232 NECROTISING FASCIITIS 2 0.0006
233 FOOD INTERACTION 1 0.0006
234 HYPERCALCAEMIA 7 0.0006
235 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
236 GLOSSITIS 2 0.0006
237 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
238 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
239 ANAL INCONTINENCE 5 0.0006
240 ESSENTIAL HYPERTENSION 1 0.0005
241 CONDUCTION DISORDER 1 0.0005
242 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
243 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
244 HYPERKALAEMIA 19 0.0005
245 DYSENTERY 1 0.0005
246 KETOACIDOSIS 4 0.0005
247 ADENOCARCINOMA OF COLON 1 0.0005
248 PROTEIN TOTAL DECREASED 2 0.0005
249 CYSTOID MACULAR OEDEMA 1 0.0005
250 PEMPHIGOID 4 0.0005
251 PARANASAL SINUS DISCOMFORT 2 0.0005
252 SLEEP DISORDER 37 0.0005
253 EARLY SATIETY 1 0.0005
254 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
255 EPIGASTRIC DISCOMFORT 2 0.0005
256 BACTERAEMIA 6 0.0005
257 PLEURISY 3 0.0005
258 RENAL CYST 4 0.0005
259 TRICUSPID VALVE INCOMPETENCE 4 0.0005
260 ENURESIS 2 0.0005
261 EAR HAEMORRHAGE 1 0.0005
262 EYELID PAIN 1 0.0005
263 PANCREATITIS ACUTE 11 0.0005
264 ABNORMAL FAECES 4 0.0005
265 HYPERURICAEMIA 2 0.0005
266 GENERALISED OEDEMA 6 0.0005
267 ACUTE CORONARY SYNDROME 4 0.0005
268 CONGESTIVE CARDIOMYOPATHY 2 0.0005
269 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
270 BLOOD UREA INCREASED 8 0.0005
271 ACUTE MYOCARDIAL INFARCTION 14 0.0005
272 CARDIAC FAILURE 38 0.0005
273 RENAL FAILURE ACUTE 20 0.0005
274 AORTIC VALVE INCOMPETENCE 2 0.0005
275 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
276 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
277 PARONYCHIA 2 0.0005
278 PRODUCT FORMULATION ISSUE 3 0.0005
279 ENDOMETRIAL CANCER 1 0.0005
280 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
281 VULVOVAGINAL DISCOMFORT 2 0.0005
282 BLOOD CREATINE INCREASED 2 0.0005
283 CATHETERISATION CARDIAC 2 0.0005
284 CEREBRAL INFARCTION 11 0.0004
285 RHINITIS ALLERGIC 2 0.0004
286 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
287 GASTRIC POLYPS 1 0.0004
288 BLOOD LOSS ANAEMIA 1 0.0004
289 IMMUNE THROMBOCYTOPENIA 2 0.0004
290 DENGUE FEVER 1 0.0004
291 PNEUMONIA BACTERIAL 4 0.0004
292 APHTHOUS STOMATITIS 1 0.0004
293 LARGE INTESTINE PERFORATION 3 0.0004
294 NEPHROGENIC ANAEMIA 2 0.0004
295 HYPOMAGNESAEMIA 6 0.0004
296 HEPATIC STEATOSIS 8 0.0004
297 GASTRITIS EROSIVE 2 0.0004
298 HEPATIC FUNCTION ABNORMAL 16 0.0004
299 DISCOURAGEMENT 1 0.0004
300 DYSMORPHISM 1 0.0004
301 GASTRIC ULCER 8 0.0004
302 PULMONARY EMBOLISM 40 0.0004
303 PRE-ECLAMPSIA 2 0.0004
304 CARDIAC TAMPONADE 2 0.0004
305 EOSINOPHIL COUNT DECREASED 1 0.0004
306 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
307 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
308 SKIN EXFOLIATION 35 0.0004
309 BREATH ODOUR 1 0.0004
310 BRONCHITIS CHRONIC 1 0.0004
311 MOUTH HAEMORRHAGE 3 0.0004
312 EYE OEDEMA 1 0.0004
313 DERMAL CYST 1 0.0004
314 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
315 CARDIOMYOPATHY 6 0.0004
316 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
317 PROTEIN URINE PRESENT 2 0.0004
318 GASTROINTESTINAL TUBE INSERTION 1 0.0004
319 DERMATITIS EXFOLIATIVE 2 0.0004
320 DYSPHORIA 2 0.0004
321 ABDOMINAL INFECTION 1 0.0004
322 CANCER PAIN 1 0.0004
323 HYPOPHAGIA 10 0.0004
324 PHLEBITIS 2 0.0004
325 PERIPHERAL VASCULAR DISORDER 2 0.0004
326 BLOOD CHLORIDE DECREASED 1 0.0004
327 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
328 VARICOSE VEIN 2 0.0004
329 HYPOALBUMINAEMIA 3 0.0004
330 SERUM FERRITIN INCREASED 2 0.0004
331 RENAL PAIN 4 0.0004
332 PHARYNGOLARYNGEAL PAIN 2 0.0004
333 ANIMAL BITE 1 0.0004
334 BREAST SWELLING 1 0.0004
335 FRUSTRATION TOLERANCE DECREASED 3 0.0004
336 BLOOD POTASSIUM INCREASED 6 0.0004
337 CHONDROPATHY 1 0.0004
338 POLYURIA 3 0.0004
339 APPLICATION SITE HAEMORRHAGE 1 0.0004
340 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
341 CHOLECYSTITIS INFECTIVE 1 0.0004
342 C-REACTIVE PROTEIN INCREASED 13 0.0004
343 ENDOTRACHEAL INTUBATION 1 0.0004
344 ASTHMA 40 0.0004
345 CATARACT 21 0.0004
346 EJACULATION DISORDER 1 0.0004
347 GRANULOCYTOPENIA 2 0.0004
348 BLOOD URIC ACID INCREASED 2 0.0003
349 BILIARY COLIC 1 0.0003
350 NEUTROPHIL COUNT DECREASED 14 0.0003
351 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
352 URINE ODOUR ABNORMAL 2 0.0003
353 LYMPHOCYTE COUNT DECREASED 6 0.0003
354 CATARACT OPERATION 2 0.0003
355 BLOOD GLUCOSE DECREASED 16 0.0003
356 OROPHARYNGEAL DISCOMFORT 3 0.0003
357 CENTRAL VENOUS CATHETERISATION 1 0.0003
358 BONE MARROW DISORDER 1 0.0003
359 ADRENAL INSUFFICIENCY 4 0.0003
360 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
361 NOCTURIA 4 0.0003
362 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
363 NEPHROPATHY 3 0.0003
364 ACUTE KIDNEY INJURY 49 0.0003
365 ABDOMINAL ADHESIONS 1 0.0003
366 DRUG EFFECT INCREASED 1 0.0003
367 FAECAL CALPROTECTIN INCREASED 1 0.0003
368 HAEMATEMESIS 8 0.0003
369 METABOLIC ACIDOSIS 10 0.0003
370 ENTERITIS 2 0.0003
371 UNRESPONSIVE TO STIMULI 8 0.0003
372 HERPES SIMPLEX 2 0.0003
373 FACET JOINT SYNDROME 1 0.0003
374 HEPATOMEGALY 3 0.0003
375 SOMNAMBULISM 2 0.0003
376 HYPOGAMMAGLOBULINAEMIA 2 0.0003
377 DEAFNESS NEUROSENSORY 1 0.0003
378 CORONAVIRUS INFECTION 2 0.0003
379 APPETITE DISORDER 2 0.0003
380 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
381 CEREBRAL HAEMATOMA 1 0.0003
382 PLEURAL EFFUSION 18 0.0003
383 BRONCHOPNEUMONIA 1 0.0003
384 ECCHYMOSIS 2 0.0003
385 APLASIA PURE RED CELL 1 0.0003
386 BLOOD CREATININE ABNORMAL 1 0.0003
387 BLADDER CANCER 17 0.0003
388 RHABDOMYOLYSIS 12 0.0003
389 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
390 PETECHIAE 3 0.0003
391 AORTIC STENOSIS 1 0.0003
392 CAROTID ARTERY STENOSIS 1 0.0003
393 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
394 INCONTINENCE 3 0.0003
395 DUODENAL ULCER 2 0.0003
396 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
397 CONJUNCTIVAL HYPERAEMIA 1 0.0003
398 BONE LESION 1 0.0003
399 BLOOD GLUCOSE INCREASED 52 0.0003
400 DIABETES MELLITUS 21 0.0003
401 FLUID OVERLOAD 4 0.0003
402 INTENTIONAL UNDERDOSE 2 0.0003
403 BLOOD GLUCOSE FLUCTUATION 3 0.0003
404 MELAENA 6 0.0003
405 DENTAL CARIES 3 0.0003
406 HYPOPHOSPHATAEMIA 2 0.0003
407 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
408 INTERSTITIAL LUNG DISEASE 13 0.0003
409 MITRAL VALVE INCOMPETENCE 3 0.0003
410 CATHETER SITE INFECTION 1 0.0003
411 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
412 HAEMATURIA 9 0.0003
413 MICTURITION URGENCY 3 0.0003
414 RENAL FAILURE CHRONIC 2 0.0003
415 ATRIOVENTRICULAR BLOCK 2 0.0003
416 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
417 ELECTROLYTE IMBALANCE 3 0.0003
418 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
419 CARDIOPULMONARY FAILURE 1 0.0003
420 SPLENOMEGALY 3 0.0003
421 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
422 COVID-19 PNEUMONIA 3 0.0003
423 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
424 NEUROPATHY PERIPHERAL 24 0.0003
425 CEREBRAL ATROPHY 1 0.0003
426 AZOTAEMIA 1 0.0003
427 WRIST FRACTURE 3 0.0003
428 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
429 CANDIDIASIS 1 0.0002
430 BLEPHARITIS 1 0.0002
431 ARTERIOSPASM CORONARY 1 0.0002
432 BLOOD PRESSURE INCREASED 38 0.0002
433 RHINITIS 2 0.0002
434 STENT PLACEMENT 2 0.0002
435 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
436 ARTHRITIS BACTERIAL 1 0.0002
437 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
438 APPLICATION SITE EXFOLIATION 1 0.0002
439 OSTEONECROSIS OF JAW 6 0.0002
440 SPINAL COMPRESSION FRACTURE 2 0.0002
441 CYTOMEGALOVIRUS INFECTION 4 0.0002
442 NEPHROLITHIASIS 11 0.0002
443 LIVE BIRTH 2 0.0002
444 BUNDLE BRANCH BLOCK LEFT 1 0.0002
445 ERECTILE DYSFUNCTION 6 0.0002
446 MYOPATHY 2 0.0002
447 DISEASE RECURRENCE 11 0.0002
448 CORONARY ARTERY DISEASE 7 0.0002
449 BLOOD CREATININE INCREASED 15 0.0002
450 URINE OUTPUT DECREASED 2 0.0002
451 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
452 DIVERTICULUM INTESTINAL 1 0.0002
453 PAIN IN EXTREMITY 67 0.0002
454 SOPOR 3 0.0002
455 LUNG INFILTRATION 2 0.0002
456 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
457 DRUG ERUPTION 4 0.0002
458 RESPIRATORY RATE INCREASED 2 0.0002
459 CHEST DISCOMFORT 23 0.0002
460 CARDIAC FAILURE CONGESTIVE 18 0.0002
461 PULMONARY OEDEMA 10 0.0002
462 MYOSITIS 2 0.0002
463 LOSS OF LIBIDO 2 0.0002
464 OSTEOMYELITIS 4 0.0002
465 GASTROINTESTINAL CARCINOMA 2 0.0002
466 PRODUCT AVAILABILITY ISSUE 5 0.0002
467 CORONARY ARTERY OCCLUSION 3 0.0002
468 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
469 RETINAL DETACHMENT 2 0.0002
470 OVARIAN CANCER 2 0.0002
471 UROSEPSIS 2 0.0002
472 HYPOKALAEMIA 10 0.0002
473 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
474 MENTAL STATUS CHANGES 6 0.0002
475 FEELING OF DESPAIR 1 0.0002
476 HEPATIC CIRRHOSIS 4 0.0002
477 BLOOD SODIUM DECREASED 4 0.0002
478 PROTEINURIA 4 0.0002
479 URINARY RETENTION 7 0.0002
480 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
481 PANCREATIC CARCINOMA 6 0.0002
482 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
483 ENTEROCOCCAL INFECTION 1 0.0002
484 RENAL TUBULAR NECROSIS 2 0.0002
485 LIVER DISORDER 9 0.0002
486 RENAL IMPAIRMENT 17 0.0002
487 LIGAMENT SPRAIN 2 0.0002
488 ABDOMINAL TENDERNESS 1 0.0002
489 ANEURYSM 1 0.0002
490 SALIVARY HYPERSECRETION 2 0.0002
491 ERYSIPELAS 1 0.0002
492 CORONARY ARTERY STENOSIS 1 0.0002
493 CELLULITIS 10 0.0002
494 EMPHYSEMA 2 0.0002
495 ABDOMINAL PAIN LOWER 5 0.0002
496 CORONARY ARTERIAL STENT INSERTION 1 0.0002
497 OEDEMA PERIPHERAL 24 0.0002
498 DYSLIPIDAEMIA 1 0.0002
499 DRY THROAT 2 0.0002
500 FEBRILE NEUTROPENIA 13 0.0002
501 NEUTROPHIL COUNT INCREASED 2 0.0002
502 FEMORAL NECK FRACTURE 1 0.0002
503 DEVICE RELATED INFECTION 3 0.0002
504 COGNITIVE DISORDER 9 0.0002
505 EYE DISCHARGE 2 0.0002
506 DRUG-INDUCED LIVER INJURY 6 0.0002
507 CONDITION AGGRAVATED 58 0.0002
508 CATATONIA 1 0.0002
509 GASTRITIS 5 0.0002
510 DECREASED APPETITE 44 0.0002
511 PANCREATITIS 10 0.0002
512 JOINT DISLOCATION 2 0.0002
513 PNEUMOTHORAX 3 0.0002
514 JOINT INJURY 4 0.0002
515 DYSPNOEA EXERTIONAL 7 0.0002
516 ERYTHEMA OF EYELID 1 0.0002
517 CHRONIC KIDNEY DISEASE 14 0.0002
518 LIMB INJURY 5 0.0002
519 SEPTIC SHOCK 8 0.0002
520 ANAEMIA 35 0.0002
521 CONSTIPATION 40 0.0002
522 ANXIETY 52 0.0002
523 OSTEONECROSIS 6 0.0002
524 CHOKING SENSATION 1 0.0002
525 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
526 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
527 VENTRICULAR FIBRILLATION 2 0.0002
528 MALNUTRITION 2 0.0002
529 PERICARDITIS 3 0.0002
530 ANGIOPATHY 1 0.0002
531 TYPE 2 DIABETES MELLITUS 6 0.0002
532 FACE OEDEMA 3 0.0002
533 HYPONATRAEMIA 10 0.0002
534 CHOLECYSTITIS ACUTE 1 0.0002
535 MUSCULAR WEAKNESS 20 0.0002
536 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
537 ANGINA PECTORIS 5 0.0002
538 EXERCISE TOLERANCE DECREASED 1 0.0002
539 RENAL DISORDER 8 0.0002
540 DYSPHONIA 10 0.0002
541 METASTASES TO LIVER 3 0.0002
542 COLD SWEAT 3 0.0002
543 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
544 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
545 ISCHAEMIC STROKE 3 0.0002
546 THIRST 3 0.0002
547 POLLAKIURIA 7 0.0002
548 HYPERLIPIDAEMIA 2 0.0002
549 MUSCLE RIGIDITY 2 0.0002
550 GOUT 3 0.0002
551 RESPIRATORY DISORDER 5 0.0002
552 POLYNEUROPATHY 2 0.0002
553 GASTROENTERITIS VIRAL 3 0.0002
554 OEDEMA 9 0.0002
555 SCHIZOPHRENIA 2 0.0002
556 END STAGE RENAL DISEASE 3 0.0002
557 FOETAL GROWTH RESTRICTION 1 0.0002
558 DERMATITIS ACNEIFORM 1 0.0002
559 PNEUMONIA 53 0.0002
560 DYSURIA 6 0.0002
561 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
562 INJECTION SITE EXTRAVASATION 2 0.0002
563 CONJUNCTIVITIS 3 0.0002
564 CHOLANGITIS 1 0.0002
565 PHARYNGITIS 2 0.0002
566 CYST 2 0.0002
567 APPLICATION SITE IRRITATION 2 0.0002
568 AGEUSIA 4 0.0002
569 PNEUMONIA ASPIRATION 4 0.0002
570 PEMPHIGUS 2 0.0002
571 COVID-19 28 0.0002
572 INTESTINAL OBSTRUCTION 6 0.0002
573 FRACTURE 3 0.0002
574 DEHYDRATION 21 0.0002
575 DYSPNOEA 89 0.0002
576 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
577 HIATUS HERNIA 2 0.0002
578 EAR PAIN 3 0.0002
579 INJECTION SITE INDURATION 2 0.0002
580 APPLICATION SITE VESICLES 1 0.0002
581 HYPOAESTHESIA 23 0.0002
582 MUSCULOSKELETAL PAIN 8 0.0002
583 APPLICATION SITE ERYTHEMA 4 0.0002
584 TOOTH INFECTION 2 0.0002
585 PULMONARY CONGESTION 2 0.0002
586 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
587 OROPHARYNGEAL PAIN 14 0.0002
588 RENAL FAILURE 20 0.0002
589 EYE HAEMORRHAGE 2 0.0001
590 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
591 JAUNDICE 4 0.0001
592 COLITIS ISCHAEMIC 1 0.0001
593 FREQUENT BOWEL MOVEMENTS 4 0.0001
594 BLOOD BILIRUBIN INCREASED 4 0.0001
595 WEIGHT INCREASED 33 0.0001
596 FALL 49 0.0001
597 TACHYPNOEA 2 0.0001
598 DRUG TOXICITY 2 0.0001
599 IMPAIRED GASTRIC EMPTYING 2 0.0001
600 HYPERTENSION 31 0.0001
601 EYE MOVEMENT DISORDER 1 0.0001
602 CROHN'S DISEASE 1 0.0001
603 PERIPHERAL COLDNESS 2 0.0001
604 DIVERTICULITIS 4 0.0001
605 HUNGER 2 0.0001
606 APHONIA 2 0.0001
607 BURNING SENSATION 10 0.0001
608 SKIN REACTION 2 0.0001
609 LYMPHADENOPATHY 5 0.0001
610 EATING DISORDER 3 0.0001
611 PARALYSIS 2 0.0001
612 IMPAIRED QUALITY OF LIFE 2 0.0001
613 HYPERTHYROIDISM 2 0.0001
614 HYPOKINESIA 2 0.0001
615 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
616 ABDOMINAL DISCOMFORT 23 0.0001
617 GASTROENTERITIS 2 0.0001
618 CHILLS 16 0.0001
619 ASCITES 4 0.0001
620 ANGIOEDEMA 6 0.0001
621 URINARY INCONTINENCE 4 0.0001
622 ARTHROPOD BITE 1 0.0001
623 RASH MACULO-PAPULAR 3 0.0001
624 RENAL INJURY 4 0.0001
625 DUODENAL ULCER PERFORATION 1 0.0001
626 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
627 HAEMORRHAGE INTRACRANIAL 2 0.0001
628 SNEEZING 3 0.0001
629 ABDOMINAL PAIN 31 0.0001
630 BLOOD POTASSIUM DECREASED 4 0.0001
631 BREAST TENDERNESS 1 0.0001
632 LACRIMATION INCREASED 4 0.0001
633 DRUG INTERACTION 21 0.0001
634 AORTIC ANEURYSM 1 0.0001
635 PLATELET COUNT DECREASED 14 0.0001
636 INSURANCE ISSUE 2 0.0001
637 SYNCOPE 13 0.0001
638 PERICARDIAL EFFUSION 3 0.0001
639 THYROID DISORDER 2 0.0001
640 MUSCULOSKELETAL CHEST PAIN 2 0.0001
641 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
642 EJECTION FRACTION DECREASED 2 0.0001
643 APNOEA 1 0.0001
644 SWOLLEN TONGUE 4 0.0001
645 GASTROINTESTINAL INFLAMMATION 1 0.0001
646 SINUSITIS 13 0.0001
647 MYOCARDIAL INFARCTION 22 0.0001
648 PREMATURE DELIVERY 2 0.0001
649 SCIATICA 2 0.0001
650 ATRIAL FLUTTER 1 0.0001
651 HEPATIC CANCER 3 0.0001
652 RHINORRHOEA 8 0.0001
653 MUSCLE TIGHTNESS 2 0.0001
654 NEURALGIA 3 0.0001
655 ENCEPHALOPATHY 3 0.0001
656 LUNG NEOPLASM MALIGNANT 5 0.0001
657 ESCHERICHIA INFECTION 1 0.0001
658 ABDOMINAL PAIN UPPER 25 0.0001
659 INFUSION RELATED REACTION 8 0.0001
660 EMBOLISM 1 0.0001
661 EPISTAXIS 9 0.0001
662 FUNGAL INFECTION 4 0.0001
663 HAEMODIALYSIS 1 0.0001
664 OSTEOARTHRITIS 5 0.0001
665 SCAR 2 0.0001
666 DYSPHAGIA 11 0.0001
667 MULTI-ORGAN FAILURE 2 0.0001
668 PYREXIA 40 0.0001
669 STOMATITIS 7 0.0001
670 LOCAL SWELLING 2 0.0001
671 FEELING HOT 7 0.0001
672 GROIN PAIN 1 0.0001
673 CHEST PAIN 21 0.0001
674 BRADYCARDIA 6 0.0001
675 GALLBLADDER DISORDER 2 0.0001
676 PRODUCT USE ISSUE 21 0.0001
677 WEIGHT DECREASED 31 0.0001
678 TOOTHACHE 2 0.0001
679 RESTLESS LEGS SYNDROME 2 0.0001
680 BONE DISORDER 2 0.0001
681 TREATMENT NONCOMPLIANCE 6 0.0001
682 HAEMATOCHEZIA 6 0.0001
683 RESPIRATORY DISTRESS 3 0.0001
684 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
685 NASOPHARYNGITIS 20 0.0001
686 GRAND MAL CONVULSION 1 0.0001
687 FLUSHING 11 0.0001
688 FEELING COLD 3 0.0001
689 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
690 PANCYTOPENIA 6 0.0001
691 WOUND 3 0.0001
692 ASTHENIA 40 0.0001
693 PHOTOPHOBIA 2 0.0001
694 DYSARTHRIA 4 0.0001
695 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
696 ARRHYTHMIA 5 0.0001
697 FOOT FRACTURE 2 0.0001
698 HAEMATOTOXICITY 1 0.0001
699 SLEEP APNOEA SYNDROME 2 0.0001
700 ACUTE RESPIRATORY FAILURE 2 0.0001
701 GLAUCOMA 2 0.0001
702 ATELECTASIS 1 0.0001
703 PRESCRIBED OVERDOSE 2 0.0001
704 BACK PAIN 24 0.0001
705 LIVER FUNCTION TEST ABNORMAL 3 0.0001
706 DIZZINESS POSTURAL 1 0.0001
707 DYSSTASIA 3 0.0001
708 HEART RATE INCREASED 10 0.0001
709 HAEMATOCRIT DECREASED 2 0.0001
710 PRESCRIBED UNDERDOSE 2 0.0001
711 VOMITING 47 0.0001
712 BRAIN INJURY 1 0.0001
713 PREMATURE BABY 3 0.0001
714 FULL BLOOD COUNT DECREASED 2 0.0001
715 TASTE DISORDER 2 0.0001
716 PSORIATIC ARTHROPATHY 4 0.0001
717 VERTIGO 6 0.0001
718 BONE MARROW FAILURE 2 0.0001
719 FLUID RETENTION 5 0.0001
720 EUPHORIC MOOD 1 0.0001
721 EAR DISCOMFORT 1 0.0001
722 GYNAECOMASTIA 3 0.0001
723 LIMB DISCOMFORT 3 0.0001
724 INFLAMMATION 5 0.0001
725 PULMONARY HYPERTENSION 2 0.0001
726 UNDERDOSE 7 0.0001
727 CARDIO-RESPIRATORY ARREST 4 0.0001
728 KNEE ARTHROPLASTY 2 0.0001
729 HEAD INJURY 3 0.0001
730 HALLUCINATION, VISUAL 2 0.0001
731 HYPOTENSION 19 0.0001
732 PALPITATIONS 11 0.0001
733 RETCHING 2 0.0001
734 URINARY TRACT INFECTION 16 0.0001
735 BODY HEIGHT DECREASED 1 0.0001
736 MOVEMENT DISORDER 3 0.0001
737 DIARRHOEA 60 0.0001
738 SKIN CANCER 2 0.0001
739 DECREASED ACTIVITY 1 0.0001
740 BALANCE DISORDER 8 0.0001
741 BIPOLAR DISORDER 1 0.0001
742 MENTAL DISORDER 4 0.0001
743 PRODUCT DISPENSING ERROR 2 0.0001
744 CHOLELITHIASIS 3 0.0001
745 DYSPEPSIA 9 0.0001
746 ASPIRATION 1 0.0001
747 MALAISE 40 0.0001
748 STAPHYLOCOCCAL INFECTION 3 0.0001
749 PERIPHERAL SWELLING 14 0.0001
750 APPLICATION SITE PAIN 2 0.0001
751 BLOOD PRESSURE DECREASED 6 0.0001
752 VIRAL INFECTION 3 0.0001
753 MEDICATION ERROR 5 0.0001
754 TOOTH DISORDER 2 0.0001
755 COLITIS ULCERATIVE 4 0.0001
756 RASH PAPULAR 2 0.0001
757 FISTULA 1 0.0001
758 EYE PAIN 5 0.0001
759 CHROMATURIA 2 0.0001
760 MYALGIA 15 0.0001
761 APPLICATION SITE PRURITUS 2 0.0001
762 DERMATITIS CONTACT 1 0.0001
763 CHOLECYSTECTOMY 1 0.0001
764 SKIN DISCOLOURATION 4 0.0001
765 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
766 GASTRIC HAEMORRHAGE 1 0.0001
767 DELIRIUM 3 0.0001
768 DRY MOUTH 7 0.0001
769 ABDOMINAL DISTENSION 9 0.0001
770 NAUSEA 68 0.0001
771 CAESAREAN SECTION 1 0.0001
772 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
773 HYPERHIDROSIS 11 0.0001
774 SURGERY 5 0.0001
775 HOSPITALISATION 13 0.0001
776 SOMNOLENCE 17 0.0001
777 TREMOR 14 0.0001
778 BLOOD IRON DECREASED 1 0.0001
779 COMA 4 0.0001
780 CHOLECYSTITIS 1 0.0001
781 BLOOD PRESSURE FLUCTUATION 2 0.0001
782 CONTUSION 8 0.0001
783 LOCALISED INFECTION 2 0.0001
784 PARAESTHESIA 13 0.0001
785 MENTAL IMPAIRMENT 2 0.0001
786 BURSITIS 1 0.0001
787 DIZZINESS 41 0.0001
788 RESTLESSNESS 3 0.0001
789 CYTOPENIA 1 0.0001
790 LIVER INJURY 2 0.0001
791 ABNORMAL WEIGHT GAIN 1 0.0001
792 SEPSIS 9 0.0001
793 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
794 HALLUCINATION 6 0.0001
795 DERMATITIS ALLERGIC 1 0.0001
796 GASTROINTESTINAL DISORDER 7 0.0001
797 LOSS OF CONSCIOUSNESS 10 0.0001
798 THERAPY CESSATION 4 0.0001
799 HAEMOGLOBIN DECREASED 8 0.0001
800 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
801 RASH GENERALISED 2 0.0001
802 ARTHRALGIA 32 0.0001
803 DEEP VEIN THROMBOSIS 5 0.0001
804 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
805 ARTHRITIS 6 0.0001
806 BEDRIDDEN 1 0.0001
807 INSOMNIA 20 0.0001
808 ABORTION SPONTANEOUS 3 0.0001
809 JOINT SWELLING 9 0.0001
810 FATIGUE 58 0.0001
811 DISTURBANCE IN ATTENTION 4 0.0001
812 PALLOR 2 0.0001
813 MOOD ALTERED 2 0.0001
814 AKATHISIA 1 0.0001
815 DEVICE MECHANICAL ISSUE 1 0.0001
816 OSTEOPOROSIS 3 0.0001
817 SKIN LESION 2 0.0001
818 APPLICATION SITE RASH 1 0.0001
819 COMPLETED SUICIDE 6 0.0001
820 ARTHROPATHY 4 0.0001
821 ATRIAL FIBRILLATION 7 0.0001
822 INFLUENZA 8 0.0001
823 BLOOD TEST ABNORMAL 1 0.0001
824 BLINDNESS UNILATERAL 1 0.0001
825 CEREBROVASCULAR ACCIDENT 12 0.0001
826 PAIN IN JAW 2 0.0001
827 FLATULENCE 4 0.0001
828 RHEUMATOID ARTHRITIS 8 0.0001
829 INTENTIONAL DOSE OMISSION 2 0.0001
830 RED BLOOD CELL COUNT DECREASED 2 0.0001
831 RECTAL HAEMORRHAGE 3 0.0001
832 HYPERSOMNIA 2 0.0001
833 CARDIOGENIC SHOCK 1 0.0001
834 HYPOACUSIS 3 0.0001
835 HERPES ZOSTER 4 0.0001
836 LETHARGY 4 0.0001
837 EYE IRRITATION 4 0.0001
838 INTENTIONAL PRODUCT MISUSE 6 0.0001
839 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
840 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
841 AGITATION 5 0.0001
842 CONFUSIONAL STATE 11 0.0001
843 COUGH 19 0.0001
844 TACHYCARDIA 6 0.0001
845 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
846 THERAPY NON-RESPONDER 3 0.0001
847 NEUTROPENIA 9 0.0001
848 ECONOMIC PROBLEM 1 0.0001
849 THERAPEUTIC RESPONSE DECREASED 4 0.0001
850 DEVICE FAILURE 1 0.0001
851 URTICARIA 11 0.0001
852 HEADACHE 41 0.0001
853 ANKLE FRACTURE 1 0.0001
854 DELUSION 1 0.0001
855 BLOOD CHOLESTEROL INCREASED 3 0.0001
856 ACUTE MYELOID LEUKAEMIA 1 0.0001
857 BASAL CELL CARCINOMA 1 0.0001
858 OCULAR HYPERAEMIA 3 0.0001
859 HIP FRACTURE 2 0.0001
860 NIGHT SWEATS 2 0.0001
861 BACK DISORDER 1 0.0001
862 PRODUCT DOSE OMISSION ISSUE 18 0.0001
863 EYE DISORDER 2 0.0001
864 DRUG LEVEL INCREASED 1 0.0001
865 LIP SWELLING 2 0.0001
866 COAGULOPATHY 1 0.0001
867 SKIN DISORDER 2 0.0001
868 MUSCLE SPASMS 11 0.0001
869 GAIT INABILITY 2 0.0001
870 CANDIDA INFECTION 1 0.0001
871 ANGER 2 0.0001
872 CIRCULATORY COLLAPSE 1 0.0001
873 VISION BLURRED 8 0.0001
874 DEVICE DEFECTIVE 1 0.0001
875 DEVICE USE ISSUE 1 0.0001
876 EOSINOPHILIA 1 0.0001
877 HEART RATE DECREASED 2 0.0001
878 VISUAL IMPAIRMENT 7 0.0001
879 DEVICE ISSUE 5 0.0001
880 DRUG EFFECT DECREASED 3 0.0001
881 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
882 MYELOSUPPRESSION 2 0.0001
883 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
884 RESPIRATORY FAILURE 4 0.0001
885 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
886 FEELING ABNORMAL 13 0.0001
887 DRUG INEFFECTIVE 71 0.0001
888 NECK PAIN 3 0.0001
889 OFF LABEL USE 47 0.0001
890 THROMBOCYTOPENIA 6 0.0001
891 BREAST CANCER 5 0.0001
892 BLISTER 3 0.0001
893 OXYGEN SATURATION DECREASED 3 0.0001
894 TOXICITY TO VARIOUS AGENTS 9 0.0001
895 HOT FLUSH 4 0.0001
896 FEELING JITTERY 1 0.0001
897 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
898 ERUCTATION 1 0.0001
899 MEMORY IMPAIRMENT 7 0.0001
900 DISEASE PROGRESSION 6 0.0001
901 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
902 ABNORMAL BEHAVIOUR 2 0.0001
903 PAIN 31 0.0001
904 SUICIDE ATTEMPT 3 0.0000
905 PRURITUS 19 0.0000
906 DISCOMFORT 3 0.0000
907 BLINDNESS 2 0.0000
908 BODY TEMPERATURE INCREASED 1 0.0000
909 INFECTION 7 0.0000
910 RASH 21 0.0000
911 HAEMORRHAGE 5 0.0000
912 ROAD TRAFFIC ACCIDENT 2 0.0000
913 DERMATITIS 1 0.0000
914 INTENTIONAL OVERDOSE 3 0.0000
915 FAECES DISCOLOURED 1 0.0000
916 DEVICE LEAKAGE 2 0.0000
917 VAGINAL HAEMORRHAGE 2 0.0000
918 SWELLING FACE 3 0.0000
919 DEVICE DISLOCATION 2 0.0000
920 PRODUCT DOSE OMISSION 3 0.0000
921 MUSCULOSKELETAL STIFFNESS 4 0.0000
922 THROAT IRRITATION 2 0.0000
923 ADVERSE DRUG REACTION 4 0.0000
924 HEPATIC ENZYME INCREASED 3 0.0000
925 ERYTHEMA 9 0.0000
926 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
927 SUICIDAL IDEATION 4 0.0000
928 TINNITUS 2 0.0000
929 ADVERSE EVENT 4 0.0000
930 INJURY 3 0.0000
931 MULTIPLE SCLEROSIS 2 0.0000
932 GAIT DISTURBANCE 8 0.0000
933 MOBILITY DECREASED 3 0.0000
934 OVERDOSE 9 0.0000
935 DRUG INTOLERANCE 4 0.0000
936 FIBROMYALGIA 1 0.0000
937 BRONCHITIS 3 0.0000
938 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
939 DEPRESSION 9 0.0000
940 GASTRIC CANCER 1 0.0000
941 CARDIOVASCULAR DISORDER 1 0.0000
942 ANAPHYLACTIC SHOCK 1 0.0000
943 DIPLOPIA 1 0.0000
944 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
945 PSORIASIS 5 0.0000
946 NERVOUSNESS 2 0.0000
947 DEAFNESS 1 0.0000
948 ECZEMA 2 0.0000
949 ANHEDONIA 1 0.0000
950 DEPRESSED MOOD 2 0.0000
951 INJECTION SITE BRUISING 3 0.0000
952 FEAR 1 0.0000
953 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
954 RASH PRURITIC 2 0.0000
955 CARDIAC ARREST 3 0.0000
956 DRUG DOSE OMISSION 6 0.0000
957 ABNORMAL DREAMS 1 0.0000
958 DEMENTIA 1 0.0000
959 ALOPECIA 7 0.0000
960 SEIZURE 4 0.0000
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
962 APHASIA 1 0.0000
963 DEATH 27 0.0000
964 AMNESIA 2 0.0000
965 DRY SKIN 4 0.0000
966 EYE PRURITUS 1 0.0000
967 GASTRIC DISORDER 1 0.0000
968 ILLNESS 3 0.0000
969 THERAPY INTERRUPTED 2 0.0000
970 CRYING 1 0.0000
971 DYSGEUSIA 2 0.0000
972 EYE SWELLING 1 0.0000
973 INCORRECT DOSE ADMINISTERED 6 0.0000
974 DISORIENTATION 1 0.0000
975 INJECTION SITE HAEMORRHAGE 2 0.0000
976 DYSKINESIA 1 0.0000
977 PRODUCT QUALITY ISSUE 3 0.0000
978 CARDIAC DISORDER 2 0.0000
979 SWELLING 2 0.0000
980 MIGRAINE 2 0.0000
981 COLORECTAL CANCER 1 0.0000
982 DRY EYE 1 0.0000
983 AGGRESSION 1 0.0000
984 INJECTION SITE PAIN 6 0.0000
985 DERMATITIS ATOPIC 1 0.0000
986 ANAPHYLACTIC REACTION 1 0.0000
987 BONE PAIN 1 0.0000
988 EMOTIONAL DISTRESS 2 0.0000
989 HYPERSENSITIVITY 3 0.0000
990 DEVICE DIFFICULT TO USE 1 0.0000
991 DRUG DOSE OMISSION BY DEVICE 1 0.0000
992 DRUG DEPENDENCE 2 0.0000